Adamis Pharmaceuticals Corporat (ADMP) Stock Discussions on Social Media

COVID-19 package has been pass Monday’s gonna be a good day 

everything's crashing. don't worry boys

Worse management ever!!! Carlo needs to go!!! Obviously he's against making money for his shareholders!!!He only pads his own pockets!!!

I am reasonably sure that if ADMP does not get a positive response from the FDA on Zimhi. this company is headed to oblivion. That fact that Carlo does not even let shareholders know what is going on there is beyond belief. People can take good or bad news....complete silence is not the option.

What is the meaning of: Q1 corporate Highlights -> "Announced intent to sell substantially all of the assets of US Compounding to a strategic Buyer", mean? http://ir.adamispharmaceuticals.com/node/12166/html

JosephO is proving he doesn't trade stocks for a living as he claims. 2 weeks of a down market and his only focus is to troll a small company he doesn't own. Owning small amounts of 2 stocks doesn't make you a pro.

Gap fill at .81 closing price, .84 intraday almost complete. Unfortunately there’s nothing saying it stops or snaps back from there.The sooner the ZIMHI update comes whether a 2 paths approach or simply an NDA resubmission the better.They got the offering money at 1.11 and plenty of bag holder money higher so let us all know the likely not so pleasant news.If it is an NDA resubmission GET IT RIGHT!Good luck.Peace.

Adamis Pharmaceuticals Corporation (ADMP) found on their website!!!! Tempol – CapsuleAdamis has a worldwide license to use Tempol for the treatment of respiratory diseases including asthma, respiratory syncytial virus, influenza and COVID-19.Potential Indication: Respiratory Disease (COVID-19, influenza, RSV)Coronavirus disease [Novel Coronavirus Disease (COVID-19), a human betacoronavirus] represents a global health problem. Just within the U.S., the American Hospital Association estimates that the financial impact in losses for America’s hospital and health care systems could exceed 200 billion dollars by mid-2020. Most common symptoms at onset include fever, cough, sore throat, sneezing, rhinorrhoea (runny nose) and fatigue. In severe cases, this can progress to pneumonia, acute respiratory distress syndrome (ARDS), acute cardiac injury and eventually death. ARDS occurs when there is damage to the lungs resulting in fluid accumulation in the small air sacs of the lungs. This fluid causes a decrease in the oxygen supply to vital organs which can eventually lead to death.Tempol has demonstrated anti-inflammatory, anticogulant, and antioxidant activity. Tempol specifically targets ARDS, which is the major cause of death of COVID-19. Both inflammatory cytokines and reactive oxygent species (ROS) generated from cells of the immune system (macrophages and neutrophils) damage the lungs in ARDS patients. In animal models, Tempol has been shown to decrease proinflammatory cytokines (cytokine storm) such as TNF-α, IL-Iβ, IL-6, IL-10, NF-kβ, ICAM-1, HIF-1a, HIF-2a and others. In addition, Tempol works as an antioxidant and decreases the harmful effects of ROS. ROS is a type of unstable molecule that contains oxygen and easily reacts with other molecules in the cell. It can cause damage to all macromolecules, i.e., lipids, DNA, RNA and proteins. In addition, Tempol has also been shown to decrease platelet aggregation and clotting, a problem observed in many COVID-19 patients. Published articles describing animal models of ARDS show Tempol to cause a decrease in lung inflammation and preserve lung pathology associated with acute and chronic lung injury. Additional published studies, in which animals were infected with betacoronavirus, show that Tempol treatment resulted in increased survival and decreased viral load. Taken together, this scientific data argue for the use of Tempol in preventing and treating the most severe death related lung manifestation of COVID-19. Tempol has already been shown to be safe in multiple human clinical studies.

Adamis Pharmaceuticals Corporation has great products and for Covid 19 !!! LINK>>>> https://www.adamispharmaceuticals.com/tempol-capsule/

How did I get suckered into this stock 🤣🤦🏻‍♂️ lesson learned!

Where’s everyone at? My average is 1.52 ( yeah I know) if my all’s were bigger I’d sell all my Tesla and go all in at 1.01. But I got shrinkage.

TNXP label approval by FDA. $4 close today

Let’s show to the shorter the real game

ADMP regained NASDAQ compliance.On February 9, 2021, Adamis Pharmaceuticals Corporation (the “Company”) received a letter from the Listing Qualifications Department of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that as a result of the closing bid price of the Company’s common stock having been at $1.00 per share or greater for at least ten consecutive business days, the Company has regained compliance with Nasdaq’s minimum bid price requirement under Nasdaq's Marketplace Rule 5550(a)(2) for continued listing on The NASDAQ Capital Market, and the matter is now closed.http://ir.adamispharmaceuticals.com/static-files/75b86f53-e3cd-4c83-9a6a-87c192125a22

Wall Street analysts have a consensus price target for the stock at $1.5, which means that the shares’ value could jump 33.93% from current levels. The projected low price target is $1.5 while the price target rests at a high of $1.5.

Any one seen ADMP per market shoot up to 1.68? Something big news out any time...... $3 to 5 easy. FDA green light for ADMP already.

How long can a company survive ' on a wing and a prayer " ? They are hoping Zimhi works out, they are hoping that Tempol works out, they are hoping that Walgreens can sell Symjepi at a profit, they are hoping they can unload US Compounding, they are hoping for hope but there seems to be little sign of hope, I am hoping for new management, that would give me hope.

God I'm so glad I invested in admp. Makes me so happy each day. 🥲 -31% still holding

adamis investors

When do you guys think a great jump will occur? Since they green lighted to proceed with their researches a big jump into green should have happened!